Case Study
Precision Data Integration for Precision Medicine
A case study on how a range of precise data sources can be utilized at different stages of the patient experience for the CAR T-Cell market
Dan Winkelman, Offering Design Suite Director, Advisory & Brand Intelligence, IQVIA
Jul 22, 2025

Unlock the future of oncology treatment with Precision Data for Precision Medicine, a compelling deep dive into how integrated data strategies are transforming CAR T-Cell therapy. This breakthrough class of treatments harnesses patients' own immune systems to fight aggressive cancers, but its complexity, cost, and limited patient eligibility demand a new level of insight. This case study explores how combining primary and secondary data sources can illuminate every stage of the patient journey, from diagnosis and referral to treatment and post-care, enabling manufacturers to optimize outcomes and minimize missed opportunities.

Whether you're a marketer, brand strategist, or clinical leader in the life sciences industry, this case study offers actionable intelligence drawn from real-world data, including referral patterns, treatment center dynamics, and post-therapy follow-up. Learn how tools like IQVIA’s BrandImpact™ and the CAR T-Cell Monitor provide clarity on patient eligibility, barriers to treatment, and the commercial impact of certified centers.

Download the case study to learn how precision data can drive precision medicine, and help your organization stay ahead in a rapidly evolving therapeutic landscape.

Related solutions

Contact Us